Product NDC: | 0378-7096 |
Proprietary Name: | Bromocriptine Mesylate |
Non Proprietary Name: | bromocriptine mesylate |
Active Ingredient(s): | 5 mg/1 & nbsp; bromocriptine mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-7096 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077226 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110504 |
Package NDC: | 0378-7096-93 |
Package Description: | 30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0378-7096-93) |
NDC Code | 0378-7096-93 |
Proprietary Name | Bromocriptine Mesylate |
Package Description | 30 CAPSULE in 1 BOTTLE, UNIT-DOSE (0378-7096-93) |
Product NDC | 0378-7096 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | bromocriptine mesylate |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20110504 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | BROMOCRIPTINE MESYLATE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |